ProCertus BioPharm
A oncology-based pharmaceutical company developing therapeutics for the protection of cancer patients from radiotherapy and chemotherapy side effects
1
Funding Rounds
$1.7m
Money raised
Overview
A oncology-based pharmaceutical company developing therapeutics for the protection of cancer patients from radiotherapy and chemotherapy side effects
- Website:
Funding series
Funding Series Analysis
The company ProCertus BioPharm has raised a total of $1.7m in funding over 1 rounds.
Key Insights:
- ProCertus BioPharm Series A round: $1.7m
ProCertus BioPharm Series A round
$1.7m
Industries
ProCertus BioPharm is active in the following industries: